ATOMS Moderate & Severe SUI
ATOMS Moderate & Severe SUI
ATOMS Moderate & Severe SUI
Hydraulic, Adjustable Substitute Sphincter System for Male SUI
Treatment of male stress urinary incontinence still presents a significant challenge, particularly after radical prostatectomy. The ATOMS System combines a range of features to provide an effective, patient-friendly means of managing all grades of SUI.
The ATOMS advantage
Adjustability
There is no surgical reintervention required to adjust the system, the treating physician can simply alter the volume of liquid in the cushion via the access port. Patient-specific adjustment to effect a change in continence status is possible at any time, even in the long-term.¹
Hydraulic operation
ATOMS is made up entirely of components that function hydraulically, thereby saving patients from the difficulties caused by defects which may occur in mechanical components months or years after the implantation.
User-friendly
ATOMS provides effective treatment for mild to severe stress urinary incontinence, even after radiotherapy.
Patients can urinate freely without having to activate a mechanical component. This means the system is also suitable for patients suffering from dementia, or whose cognitive skills may be expected to regress over time. Patients with joint pain (e.g. gout) also benefit from not having to operate the system manually.
Substitutes sphincter function
The suburethral substitute sphincter cushion is located in the middle of the mesh fixation tape and is filled via the port-catheter connection after the operation.
This cushion ensures a gentle, evenly-distributed pressure on the bulbospongiosus muscle. Pressure on the urethra is kept to a minimum and the risk of urethral erosion is significantly reduced.
Four-point fixation
The integrated mesh arms are drawn back around to the middle of the implant to secure the system in place. This eliminates the need for any fasteners or screws, and ensures a symmetrical, 4-point auto fixation.
Proven long-term effectiveness
The results of the latest clinical article demonstrates the long-term safety and efficacy of ATOMS in the treatment of incontinence in men, following invasive prostate treatment.
- Up to 7 years follow up data
- A multinational retrospective study of 287 men implanted with ATOMS – 1st generation to the 3rd generation of the device included
- 89% of patients treated had moderate or severe SUI
- Median follow up of 31 months with a range of 10 to 54 months
- Overall success rate of 90% and dry rate of 64% after 3 post-op adjustments
- 0% urethral erosion rate
- Despite 25% of the cohort having received radiotherapy treatment, the ATOMS delivered overall results of an 81% dry rate and 92% overall success rate*
To contact Endotherapeutics Pty Ltd about ATOMS Moderate & Severe SUI use Get a quote.
Hydraulic, Adjustable Substitute Sphincter System for Male SUI
Treatment of male stress urinary incontinence still presents a significant challenge, particularly after radical prostatectomy. The ATOMS System combines a range of features to provide an effective, patient-friendly means of managing all grades of SUI.
The ATOMS advantage
Adjustability
There is no surgical reintervention required to adjust the system, the treating physician can simply alter the volume of liquid in the cushion via the access port. Patient-specific adjustment to effect a change in continence status is possible at any time, even in the long-term.¹
Hydraulic operation
ATOMS is made up entirely of components that function hydraulically, thereby saving patients from the difficulties caused by defects which may occur in mechanical components months or years after the implantation.
User-friendly
ATOMS provides effective treatment for mild to severe stress urinary incontinence, even after radiotherapy.
Patients can urinate freely without having to activate a mechanical component. This means the system is also suitable for patients suffering from dementia, or whose cognitive skills may be expected to regress over time. Patients with joint pain (e.g. gout) also benefit from not having to operate the system manually.
Substitutes sphincter function
The suburethral substitute sphincter cushion is located in the middle of the mesh fixation tape and is filled via the port-catheter connection after the operation.
This cushion ensures a gentle, evenly-distributed pressure on the bulbospongiosus muscle. Pressure on the urethra is kept to a minimum and the risk of urethral erosion is significantly reduced.
Four-point fixation
The integrated mesh arms are drawn back around to the middle of the implant to secure the system in place. This eliminates the need for any fasteners or screws, and ensures a symmetrical, 4-point auto fixation.
Proven long-term effectiveness
The results of the latest clinical article demonstrates the long-term safety and efficacy of ATOMS in the treatment of incontinence in men, following invasive prostate treatment.
- Up to 7 years follow up data
- A multinational retrospective study of 287 men implanted with ATOMS – 1st generation to the 3rd generation of the device included
- 89% of patients treated had moderate or severe SUI
- Median follow up of 31 months with a range of 10 to 54 months
- Overall success rate of 90% and dry rate of 64% after 3 post-op adjustments
- 0% urethral erosion rate
- Despite 25% of the cohort having received radiotherapy treatment, the ATOMS delivered overall results of an 81% dry rate and 92% overall success rate*
To contact Endotherapeutics Pty Ltd about ATOMS Moderate & Severe SUI use Get a quote.
ATOMS is a hydraulic, adjustable substitute sphincter system that manages male stress urinary incontinence across mild, moderate and severe grades. A treating physician changes liquid volume in the cushion through an access port, adjusting continence without surgical reintervention, including over the long term. Men with dementia or joint pain can urinate without manually activating a mechanical component.
- Cushion distributes gentle pressure evenly across the bulbospongiosus muscle
- Mesh arms provide symmetrical four-point fixation without fasteners or screws
- Multinational retrospective study of 287 men; up to 7 years’ follow-up data
- 64% dry rate after 3 post-operative adjustments
- Study reported 0% urethral erosion rate
Source: listing by Endotherapeutics Pty Ltd on MedicalSearch · Updated 31 Oct 2026
AI Overview is generated by artificial intelligence and may contain mistakes.
Written by AI from the listing by Endotherapeutics Pty Ltd on MedicalSearch. It is meant to use only what that listing says, but it can still get details wrong, so check them with the supplier before you buy.
Thanks for your feedback.
- Your delivery location?
- NSW
- VIC
- QLD
- SA
- WA
- NT
- ACT
- TAS
- New Zealand
- Papua New Guinea
- Afghanistan
- Albania
- Algeria
- Andorra
- Angola
- Antigua and Barbuda
- Argentina
- Armenia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- Brunei
- Bulgaria
- Burkina Faso
- Burma
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Central African Republic
- Chad
- Chile
- China
- Colombia
- Comoros
- Congo (Brazzaville)
- Congo (Kinshasa)
- Costa Rica
- Côte d'Ivoire
- Croatia
- Cuba
- Cyprus
- Czechia
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Fiji
- Finland
- France
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Greece
- Grenada
- Guatemala
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Holy See
- Honduras
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, North
- Korea, South
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Mauritania
- Mauritius
- Mexico
- Federated States of Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Morocco
- Mozambique
- Namibia
- Nauru
- Nepal
- Netherlands
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Norway
- Oman
- Pakistan
- Palau
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Rwanda
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor-Leste
- Togo
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Tuvalu
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Uruguay
- Uzbekistan
- Vanuatu
- Venezuela
- Vietnam
- Yemen
- Zambia
- Zimbabwe
- NSW
- VIC
- QLD
- SA
- WA
- NT
- ACT
- TAS
- New Zealand
- Papua New Guinea
- Afghanistan
- Albania
- Algeria
- Andorra
- Angola
- Antigua and Barbuda
- Argentina
- Armenia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Botswana
- Brazil
- Brunei
- Bulgaria
- Burkina Faso
- Burma
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Central African Republic
- Chad
- Chile
- China
- Colombia
- Comoros
- Congo (Brazzaville)
- Congo (Kinshasa)
- Costa Rica
- Côte d'Ivoire
- Croatia
- Cuba
- Cyprus
- Czechia
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Fiji
- Finland
- France
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Greece
- Grenada
- Guatemala
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Holy See
- Honduras
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, North
- Korea, South
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Mauritania
- Mauritius
- Mexico
- Federated States of Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Morocco
- Mozambique
- Namibia
- Nauru
- Nepal
- Netherlands
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Norway
- Oman
- Pakistan
- Palau
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Rwanda
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor-Leste
- Togo
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Tuvalu
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Uruguay
- Uzbekistan
- Vanuatu
- Venezuela
- Vietnam
- Yemen
- Zambia
- Zimbabwe
Surgical Laser Machine | Neov1470
ATOMS Moderate & Severe SUI
Simai Genius Morcellator System
Combat Bladder Recirculation
Macroplastique Mild SUI (Stress Urinary Incontinence)
Absorbable Skin Stapler | INSORB
Electromechanical Laparoscopic Device | HandX
NeoPulse BioContouring Device
Medical Endermologie | CELLU M6 Alliance
Beauty Endermologie | CELLU M6 Alliance
Huber 360 Evolution Neuro-Physical Training
Connect Face Treatment | Mobilift M6
Body Composition Analyser | InBody 970
Body Water Analysis | InBody BWA 2.0
Innovex Single-Use Flexible Cystoscope
Innovex Single-Use 7.5 Fr Flexible Ureteroscope
Innovex Single-Use Flexible Choledochoscope
LTA CSSD Brushes
Lone Star Retractor
Piezosurgery Bone Dissection
Thanks for your help!
Sorry! Unable to submit your request at this time. Please try again later.
Report this product
